Predictors of Warfarin Time in Therapeutic Range after Continuous‐Flow Left Ventricular Assist Device

Introduction Patients with a continuous‐flow left ventricular assist device (CF‐LVAD) require anticoagulation with a vitamin K antagonist to prevent thromboembolic events. Fluctuations in the international normalized ratio are associated with both increased thrombotic and bleeding episodes. To date,...

Ausführliche Beschreibung